Current Issues of Pharmacy and Medical Sciences

Molecular-oriented treatment of metastatic kidney cancer

Annales UMCS, Sectio DDD, Pharmacia, Vol. XXIV, N 4, 12

ELŻBIETA STAROSŁAWSKA1, KRZYSZTOF J. CZARNOCKI1,2,
TOMASZ KUBIATOWSKI1, JUSTYNA SZUMIŁO3,FRANCISZEK BURDAN4

1 Department of Chemotherapy, St John’s Cancer Center, Lublin, Poland

2 Occupational Hygiene and Ergonomics Dept., Lublin University of Technology, Lublin, Poland

3 Department of Clinical Pathomorphology, Medical University in Lublin, Poland

4 Radio-Diagnostic Dept., St John’s Cancer Center, Lublin, Poland

Abstract

According the latest trial results, chemotherapy and hormone treatment of metastatic kidney cancer seems to be ineffective. The most recent study results show that the response to treatment is on the level of statistical error – 5%, chemotherapy lacks effectiveness. The analysis of the effectiveness of specified drugs resulted in failure.

The paper presents the treatment characteristics – treatment and recommendation levels of metastatic kidney cancer, as well as effectiveness of different treatment algorithms.

In conclusion we stated that the introduction of new drugs oriented toward the molecular treatment improved the prognosis for the patients suffering from metastatic renal cell carcinoma. During the period of molecular treatment statistically significant prolongation of the survival time has been achieved.

Files to download

Keywords

metastatic kidney carcinoma, therapies, hormone treatment, prognostic factors

Calendar

April 2021

Mon Tue Wed Thu Fri Sat Sun
      01 02 03 04
05 06 07 08 09 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30